
Phase 4 Studies Support Alternative Pegloticase Dosing Regimens for Uncontrolled Gout, with Orrin Troum, MD
New phase 4 studies of pegloticase support the feasibility of shorter infusions and higher-dose, less frequent infusions of the pegloticase + methotrexate (MTX) coadministration for people with uncontrolled gout.1,2 These findings are from the AGILE and …